Author

V. Petit

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 2 Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Organism:mouse· 4 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell signaling & trafficking· 2 Research Focus:development & morphogenesis· 2 Research Focus:cell type annotation· 1

Frequent Co-Authors

I. Davidson· 2 shared L. Larue· 2 shared R. Le Grand· 2 shared V. Delmas· 2 shared Z. Aktary· 2 shared A. Allouch· 1 shared A. Bellacosa· 1 shared A. Bravard· 1 shared

Activity by Year

2020-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

I. Davidson

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Multi-target mode of action of Sulfodyne(R), a stabilized Sulforaphane, against pathogenic effects of SARS-CoV-2 infection

P.-H. Romeo, L. Conquet, S. Messiaen, Q. Pascal, S. G. Moreno, A. Bravard, J. Bernardino-Sgherri, N. Dereuddre-Bosquet, X. Montagutelli, R. Le Grand, V. Petit, F. Ferri

This paper shows that Sulfodyne(R), a stabilized Sulforaphane, reduces SARS-CoV-2-induced inflammation and disease severity in cell lines and animal models through mechanisms independent of NRF2 activation.

bioRxiv · Dec 18, 2023 · PreprintCell Biology

Setdb1 safeguards genome integrity in muscle stem cells to allow for regenerative myogenesis and inflammation

P. Garcia, W. Jarassier, C. Brun, L. Giordani, F. Agostini, W. H. Kung, C. Peccate, J. Ravent, S. Fall, V. Petit, T. Cheung, S. Ait-Si-Ali, F. Le Grand

This study shows that Setdb1 in muscle stem cells prevents endogenous retrovirus activation and maintains genome stability, which is essential for muscle regeneration and inflammation control.

bioRxiv · Jun 8, 2023 · PreprintCell Biology

The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection

D. Lecuyer, R. Nardacci, D. Tannous, E. Gutierrez-Mateyron, A. Deva-Nathan, F. Subra, C. Di Primio, P. Quaranta, V. Petit, C. Richetta, A. Mostefa-Kara, F. Del Nonno, L. Falasca, R. Marlin, P. Maisonnasse, , J.-L. Perfettini

This study identifies P2X7 and NLRP3 inflammasome as host factors required for SARS-CoV-2 infection and shows their role in promoting viral replication.

bioRxiv · Apr 5, 2023Microbiology

The E-cadherin-ESR1-GRPR axis defines a sex-specific metastatic pathway in melanoma

J. H. Raymond, M. Schonau, V. Petit, Z. Aktary, F. Luciani, M. Wehbe, I. Davidson, C.-L. Tomasetto, F. Mahuteau-Betzer, B. Vergier, L. Larue, V. Delmas

This study identifies an E-cadherin-ER-GRPR axis that drives sex-specific melanoma metastasis and shows GRPR inhibition reduces metastasis in vivo.

bioRxiv · Dec 2, 2022 · PreprintCancer Biology

BRN2 is a non-canonical melanoma tumor-suppressor

M. Hamm, P. Sohier, V. Petit, J. Raymond, V. Delmas, M. Le Coz, F. Gesbert, C. Kenny, Z. Aktary, M. Pouteaux, F. Rambow, A. Sarasin, A. Bellacosa, L. Sanchez-del-Campo, L. Mosteo, , L. Larue

This study identifies BRN2 as a non-canonical tumor suppressor in melanoma, showing its role in initiation and progression through PTEN regulation and PI3K signaling.

bioRxiv · Jan 13, 2021Cancer Biology

Gnotobiotic rainbow trout (Oncorhynchus mykiss) model reveals endogenous bacteria that protect against Flavobacterium columnare infection

D. PEREZ-PASCUAL, S. VENDRELL-FERNANDEZ, B. AUDRAIN, J. BERNAL-BAYARD, R. PATINO-NAVARRETE, V. PETIT, D. RIGAUDEAU, J.-M. GHIGO

bioRxiv · Jun 19, 2020Microbiology